2016
DOI: 10.1002/bdd.2026
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of loxoprofen transport in Caco‐2 cells: the involvement of a proton‐dependent transport system in the intestinal transport of loxoprofen

Abstract: Loxoprofen, a propionate non-steroidal anti-inflammatory drug (NSAID), is used widely in East Asian countries. However, little is known about the transport mechanisms contributing to its intestinal absorption. The objectives of this study were to characterize the intestinal transport of loxoprofen using the human intestinal Caco-2 cell model. The transport of loxoprofen was investigated in cellular uptake studies. The uptake of loxoprofen into Caco-2 cells was pH- and concentration-dependent, and was described… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…Western Blotting Western blotting was performed as described in our previous study, with minor modifications. 17) The following antibodies were used for Western blotting: MCT1 (sc-365501, diluted 1 : 250; Santa Cruz Biotechnology, Dallas, TX, U.S.A.), MCT4 (22787-1-AP, diluted 1 : 1000; ProteinTech Group, Inc., Chicago, IL, U.S.A.), hypoxia-inducible factor 1α (HIF-1α) (sc-10790, diluted 1 : 200; Santa Cruz Biotechnology), β-actin (MAB1501, diluted 1 : 1000; Millipore, Bedford, MA, U.S.A.), anti-mouse secondary antibody (1070-05, diluted 1 : 4000; Southern Biotech, Birmingham, AL, U.S.A.), and anti-rabbit secondary antibody (sc-2357, diluted 1 : 4000; Santa Cruz Biotechnology).…”
Section: Methodsmentioning
confidence: 99%
“…Western Blotting Western blotting was performed as described in our previous study, with minor modifications. 17) The following antibodies were used for Western blotting: MCT1 (sc-365501, diluted 1 : 250; Santa Cruz Biotechnology, Dallas, TX, U.S.A.), MCT4 (22787-1-AP, diluted 1 : 1000; ProteinTech Group, Inc., Chicago, IL, U.S.A.), hypoxia-inducible factor 1α (HIF-1α) (sc-10790, diluted 1 : 200; Santa Cruz Biotechnology), β-actin (MAB1501, diluted 1 : 1000; Millipore, Bedford, MA, U.S.A.), anti-mouse secondary antibody (1070-05, diluted 1 : 4000; Southern Biotech, Birmingham, AL, U.S.A.), and anti-rabbit secondary antibody (sc-2357, diluted 1 : 4000; Santa Cruz Biotechnology).…”
Section: Methodsmentioning
confidence: 99%
“…In Scheme 4a, we demonstrate the application potential of our reaction by testing it on pharmacologically active drugs. Nonsteroidal anti-inflammatory drugs (NSAIDs) were widely used, [44][45][46][47][48] and we successfully applied our reaction to substrates derived from naproxen, 46,48 loxoprofen, 44 and oxaprozin, 45 yielding the desired products 29b-31b in 60% to 72% yields. Furthermore, substrate 32b derived from probenecid which was widely used as an antigout drug, 49 underwent excel- a Reaction conditions: 1a (0.2 mmol), TsCN(0.4 mmol, 2 eq.…”
Section: Resultsmentioning
confidence: 99%